Rise in Central Nervous System (CNS) Lymphoma disease as reported by the World Health Organisation represented up to 7% of intracranial tumours around the world, according to a business intelligence report published by IndustryARC. The CNS lymphoma market will experience noticeable growth, owing to continual clinical trials that are being conducted to develop innovative formulations for reliable prognosis and treatment of the disease. Furthermore, rising concerns of the general population pertaining to this disease has also contributed to the market growth. These concerns have instigated governments of several countries to allot a higher budget expenditure towards enhancing the growth of the CNS lymphoma market. These factors are collectively ensuring market growth with a CAGR of 7.1%, during the forecast period 2018-2023. By the end of this period, the market has been evaluated to earn a market revenue of $1.1 billion.
The report is titled ‘CNS Lymphoma Market: By Prognosis Type (Immunocompetent, AIDS); By Type of Diagnosis (Lumbar Puncture of/Pathological Analysis of Cerebrospinal Fluid (CSF), Brain Biopsy Sampling, Magnetic Resonance Imaging (MRI), Computed Tomography (CT Scan), Stereotactic Biopsy, Complete Blood Count, Others); By Type of Treatment (Radiation Therapy, Chemotherapy, Steroid therapy, Targeted Therapy, Others); & By Geography Forecast Period (2018 2023).’ In this report, the analyst has focused on explaining the dynamics of the market through statistical and informative representation of market forces such as governmental investment and drug discovery.
CNS Lymphoma Market: Regional Analysis
North America has been evaluated as the geographical leader of the global CNS lymphoma market with a CAGR of 7.9% through to 2023, a regional share out of the total revenue approximated at $43.8m in 2018. The United States of America has witnessed immense investment in the healthcare sector with reported healthcare IT investment touching $7.1 billion in 2017. Furthermore, unhealthy diets and a sedentary lifestyle amongst the common population have led to an incessant increase in cancer instances, a driver creating avenues for CNS lymphoma market.
CNS Lymphoma Market: Trends and Opportunities
- Major opportunities for the growth of this market lie in the presence of a strong drug pipeline pertaining to CNS lymphoma diagnostics and treatment. Several drugs are at development stage and will be crucial in the development of a trusting consumer base.
- Key market players are investing resources in the development of low cost therapies that will not only help consumer get treatment at a subsidized rate but also benefit the companies in expanding their market share.
- The analyst of the report says, ‘one of the key areas that the CNS lymphoma market can considerably improve is boosting public-private partnerships (PPPs) in the healthcare industry. This will be pivotal in improving cancer diagnostic imaging and radiology services.’
- The market will also benefit from emerging medical technologies such as PET imaging and computerized tomography that are used to detect the response of lymphoma in multicentric settings.
The key market players of the CNS lymphoma market are concentrating on raising awareness about the disease in order to attract high healthcare expenditure for R&D of drugs. These companies are Amgen, Inc., Celgene Corporation, Cipla, Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGAA, Gilead Sciences, Johnson & Johnson, Merck & Co. Inc., and Sanofi.
Talk to one of our sales representative about the full report by providing your details in the link below:
A. Injectable Drug Delivery Market
B. Drug Delivery Market
Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
To request for a proposal, provide your details in the below link:
Mr. Venkat Reddy
Email: [email protected]
Contact Sales: +1-614-588-8538 (Ext-101)
About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.